Graphical abstract<'/> Sensitive optical detection of clinically relevant biomarkers in affordable microfluidic devices: Overcoming substrate diffusion limitations
首页> 外文期刊>Sensors and Actuators >Sensitive optical detection of clinically relevant biomarkers in affordable microfluidic devices: Overcoming substrate diffusion limitations
【24h】

Sensitive optical detection of clinically relevant biomarkers in affordable microfluidic devices: Overcoming substrate diffusion limitations

机译:负担得起的微流体设备中临床相关生物标志物的灵敏光学检测:克服底物扩散的局限性

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstractDisplay OmittedHighlightsWe unravelled the full potential of chromogenic substrates for optical detection biomarkers in microfluidic devices.Commercial chromogenic substrate formulations are suboptimum tuned to meso-scale systems.Optical detection of clinically relevant biomarkers is shown for a microfluidic device with optimized OPD:H2O2formulation.Assay times and lower limit of detection for PSA and IL-1β reduced by one order of magnitude.AbstractOne of the biggest challenges in miniaturization of optical immunoassays is the short light path distance of microchannels/microcapillaries. Protein biomarkers are often presented in circulating blood in the picomolar-femtomolar range, requiring exceptional levels of sensitivity that cannot be met with traditional chromogenic substrates and without sophisticated, bulky detection systems. This study discloses an effective strategy for increasing the sensitivity and shorten the total test time for sandwich ELISAs in microfluidic devices optically interrogated, based on enhancing enzymatic amplification. We found that activity of Horseradish Peroxidase (HRP) in mesofluidic systems is highly limited by diffusion, therefore increasing the concentration of enzymatic substrate in these systems does not translate into an enhancement in enzymatic conversation. The opposite happens in microfluidic systems due to short diffusion distances, however increased concentration of the second enzymatic substrate, hydrogen peroxide (H2O2), leads to enzyme inhibition as herein reported. Consequently, we found that the molar ratio of o-phenylenediamine (OPD) to hydrogen peroxide from commercially substrate formulations is not suitable for miniaturized systems. Sandwich ELISA quantitation of a cancer biomarker PSA and human cytokine IL-1β in fluoropolymer microfluidic strips revealed over one order of magnitude increase in sensitivity and 10-fold decrease in incubation time by simply changing the molar ratio of OPD:H2O2from 1:3 to 1:1 and increasing OPD concentration from 1 to 4mg/ml. This enhancement in enzymatic amplification offers finally the sensitivity required for optical interrogation of novel portable and affordable microfluidic devices with inexpensive and ubiquitous smartphones and flatbed scanners.
机译: 图形摘要 < ce:simple-para>省略显示 突出显示 我们展开了全部内容显色底物在微流控设备中用于光学检测生物标志物的潜力。 商用显色底物 显示了具有优化OPD:H 2 O 2 公式。 •< / ce:label> PSA和IL-1β的检测时间和检测下限降低了一个数量级。 摘要 光学免疫分析小型化的最大挑战是微通道/微毛细管的光路距离。蛋白质生物标志物通常出现在皮摩尔级至飞摩尔级的循环血液中,需要极高的灵敏度水平,而传统的生色底物和没有复杂的笨重的检测系统是无法实现的。这项研究基于增强酶促扩增,公开了一种有效的策略,可提高光学询问的微流体装置中夹心ELISA的灵敏度并缩短总测试时间。我们发现,辣根过氧化物酶(HRP)在中流系统中的活性受到扩散的极大限制,因此,增加这些系统中酶促底物的浓度不会转化为酶促对话的增强。相反,由于扩散距离短,在微流体系统中发生了相反的情况,但是第二种酶底物过氧化氢的浓度增加了(H 2 O 2 ),导致本文所述的酶抑制作用。因此,我们发现,商用底物配方中邻苯二胺(OPD)与过氧化氢的摩尔比不适合小型化系统。含氟聚合物微流控条中癌症生物标志物PSA和人细胞因子IL-1β的夹心ELISA定量分析显示,只需改变OPD:H 2 O 2 从1:3增加到1:1,OPD浓度从1增加到4mg / ml。酶促扩增的这种增强最终提供了用廉价且普遍存在的智能手机和平板扫描仪对新型便携式和负担得起的微流体设备进行光学询问所需的灵敏度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号